Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

Links shared publicly online about this topic.

244
total visits

Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators.

View full resource at news-medical.net

Tags: Cancer, Colorectal Cancer Medication, Skin Cancer, Melanoma, Drug, Phase 1 Clinical Trial, Avastin